GI and Hepatic Complications of Cancer Immunotherapy

Michigan Medicine

R. Fontana

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

Developing Novel Therapeutics for Brain Tumors in the Age of Genomic…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

E. Galanis

Could We Cure Metastatic Breast Cancer?

International Congress on Cancer Metastasis

L. Pusztai

Cancer Genomics: Molecular Profile Interpretation 101

Total Health

L. Welch

Basic Principles of Tumor Immunology

European School of Oncology

M. van den Broek

The Immunology of Immune Cell Cancers

Tanaya Shree

2024 Update in Oncologic Emergencies

UNC Lineberger Comprehensive Cancer Center

J. Stein

Characterizing the Immune Microenvironments of Brain Metastases

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

P. Siegel

Bispecific vs. Combination Therapy - PRO Combination Therapy

ImmunoTherapy Bridge 2023

A. Patnaik

Bispecific vs. Combination Therapy - PRO Bispecific

ImmunoTherapy Bridge 2023

J. Gulley

Geriatric Oncology Updates: Guidelines and Priorities for Older Pati…

OncoAlert

L. Decoster

Innovating Immunotherapy for Pancreatic Cancer

ImmunoTherapy Bridge 2023

G. Lesinski

Potential Mechanisms of Resistance to ADCs

MI&T Congressi

J. Bar

Immunotherapy and Targeted Therapy for Personalized Cancer Treatment

International Congress on Cancer Metastasis

K. Kim

Tumor Immune Microenvironment and Immunotherapy Resistance

MI&T Congressi

D. Sangiolo